SIM
ALXN

Spark Investment Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Spark Investment Management’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-15,800
Closed -$1.76M – 763
2018
Q1 		$1.76M Sell
15,800
-19,800
-56% -$2.37M 0.11% 245
2017
Q4 		$4.26M Sell
35,600
-11,900
-25% -$1.45M 0.23% 137
2017
Q3 		$6.66M Buy
47,500
+31,600
+199% +$4.29M 0.36% 82
2017
Q2 		$1.93M Hold
15,900
– – 0.12% 256
2017
Q1 		$1.93M Buy
+15,900
New +$2.05M 0.12% 260
2014
Q2 		– Sell
-15,500
Closed -$2.36M – 776
2014
Q1 		$2.36M Sell
15,500
-4,800
-24% -$763K 0.37% 76
2013
Q4 		$2.7M Buy
+20,300
New +$2.44M 0.47% 41

Other funds holding ALXN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Spark Investment Management's ALXN Position: Q2 2018 in Review

Spark Investment Management sold out of Alexion Pharmaceuticals (ALXN) in Q2 2018, closing a stake of 15,800 shares — an estimated $1.76M sold.

Spark Investment Management first reported a position in ALXN in Q4 2013 and held it in 7 quarters. The position peaked at $6.66M in Q3 2017. 600 funds tracked by Wall St. Rank hold ALXN as of Q2 2018.

  • Spark Investment Management reported no remaining Alexion Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
  • Spark Investment Management sold 15,800 Alexion Pharmaceuticals shares in Q2 2018, an estimated $1.76M.
  • Spark Investment Management first reported a position in Alexion Pharmaceuticals in Q4 2013 and held it in 7 quarters.
  • Spark Investment Management's Alexion Pharmaceuticals position peaked at $6.66M in Q3 2017.
  • 600 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q2 2018.

Based on Spark Investment Management's 13F filing for Q2 2018, filed 8 Aug 2018.